<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>v399813_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: right; margin-bottom: 0pt"><U>EXHIBIT 10.1</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-weight: bold">&nbsp;<B>LICENSE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This License Agreement
is entered into as of this 10<SUP>th</SUP> day of June, 2014 (the &ldquo;Effective Date&rdquo;), by and between Bar Ilan Research
and Development Company Ltd., a company formed under the laws of Israel, having a place of business at Bar Ilan University, Ramat
Gan, Israel (&ldquo;BIRAD&rdquo;) and T.A.B. Anti Bacterial Textiles Ltd., a company formed under the laws of Israel, having a
place of business at Ga'aton avenue 19, Nahariya, Israel (&ldquo;Licensee&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS,</B> BIRAD
is the technology commercialization subsidiary of Bar Ilan University (&ldquo;BIU&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS,</B> Professor
Aharon Gedanken of BIU and members of his research team at BIU have developed certain technology relating to sonochemical coating
of textiles with metal oxide nanoparticles, as disclosed in the Patent Rights (defined below);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS,</B> BIRAD
desires to have products based on the Patent Rights and the Technology Transfer Materials (as defined below) developed and commercialized
to benefit the public;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS,</B> Licensee
wishes to obtain a field limited license under the Patent Rights and Technology Transfer Materials in order to develop and commercialize
certain products based thereon; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, Licensee
has represented to BIRAD, in order to induce BIRAD to enter into this Agreement, that Licensee shall commit itself to diligent
efforts to develop and commercialize such products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE,</B>
the parties hereto, intending to be legally bound, hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-weight: bold">
    <TD STYLE="width: 7%; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>1.</B></FONT></td>
    <TD STYLE="font: bold 10 Times New Roman, Times, Serif; text-align: justify; width: 93%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Definitions.&nbsp;&nbsp;</B></FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Whenever used in this
Agreement with an initial capital letter, the terms defined in this Article 1, whether used in the singular or the plural, shall
have the meanings specified below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;Affiliate&rdquo;</B>
means, with respect to an entity, any person, organization or entity controlling, controlled by or under common control with, such
party. For purposes of this definition only, &ldquo;control&rdquo; of another person, organization or entity shall mean the possession,
directly or indirectly, of the power to direct or cause the direction of the activities, management or policies of such person,
organization or entity, whether through the ownership of voting securities, by contract or otherwise. Without limiting the foregoing,
control shall be presumed to exist when a person, organization or entity (a) owns or directly controls fifty percent (50%) or more
of the outstanding voting stock or other ownership interest of the other organization or entity or (b) possesses, directly or indirectly,
the power to elect or appoint fifty percent (50%) or more of the members of the governing body of the organization or other entity.
The parties acknowledge that in the case of entities organized under the laws of certain countries, the maximum percentage ownership
permitted by law for a foreign investor may be less than fifty percent (50%), and that in such cases such lower percentage shall
be substituted in the preceding sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;Calendar
Quarter&rdquo;</B> means each of the periods of three (3) consecutive calendar months ending on March 31, June 30, September 30
and December 31, for so long as this Agreement is in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;Covered
Textile&rdquo; </B>means any non-disposable textile (a) the making, using or selling of which falls within the scope of a Valid
Claim (b) that is coated with nanoparticles through the practice of a License Method and/or (c) is developed or made through the
use of Technology Transfer Material. <B> </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;Development
Milestones&rdquo; </B>means the development and commercialization milestones set forth in Exhibit A hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>1.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B>&ldquo;<FONT STYLE="font-family: Times New Roman, Times, Serif">First
Commercial Sale</FONT>&rdquo;</B> <FONT STYLE="font-family: Times New Roman, Times, Serif">means the date of the first sale by
Licensee or its Affiliate, for cash in an arm&rsquo;s length transaction, of a Licensed Product to an unaffiliated third party
for end use of such Licensed Product following (a) the commencement of marketing efforts by or on behalf of Licensee or its Affiliates
with respect to Licensed Products and (b) such time as Licensee and its Affiliates have generated Five Hundred Thousand US Dollars
($500,000) in cumulative worldwide Net Sales. For clarity, sales or other distribution for (i) use in testing or (ii) provision
of samples for test marketing or similar purposes shall not be deemed &ldquo;First Commercial Sale&rdquo;. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;Licensed
Method&rdquo;</B> means any method claimed or disclosed in the Patent Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;Licensed
Product&rdquo;</B> means any bed linen, drapery, upholstery, home textile and/or clothing that contains Covered Textile.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 76.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;Net
Sales&rdquo;</B> means the gross amount billed or invoiced by or on behalf of a Related Party on sales, leases or other transfers
of Licensed Products, less the following to the extent applicable on such sales, leases or other transfers, or and not previously
deducted from the gross invoice price: (a) customary trade, quantity or cash discounts to the extent actually allowed and taken;
(b) amounts actually repaid or credited by reason of rejection or return of any previously sold, leased or otherwise transferred
Licensed Products; (c) customer freight charges that are paid by or on behalf of the Related Party; (d) to the extent separately
stated on purchase orders, invoices or other documents of sale, any sales, value added or similar taxes, custom duties or other
similar governmental charges levied directly on the production, sale, transportation, delivery or use of a Licensed Product that
are paid by or on behalf of the Related Party, but not including any tax levied with respect to income; provided that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>1.8.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>in
any transfers, or provision, of Licensed Products between a Related Party and another Related Party not for the purpose of resale
by such other Related Party, Net Sales shall be equal to the fair market value of the Licensed Products so transferred or provided,
assuming an arm&rsquo;s length transaction made in the ordinary course of business, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>1.8.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>in
the event that a Related Party receives non-cash consideration for any Licensed Products or in the case of transactions not at
arm&rsquo;s length with a non-Affiliate of the Related Party, Net Sales shall be calculated based on the fair market value of such
consideration or transaction, assuming an arm&rsquo;s length transaction made in the ordinary course of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 70.9pt">Sales of Licensed
Products by a Related Party to another Related Party for resale by such Related Party shall not be deemed Net Sales. Instead, Net
Sales shall be determined based on the gross amount billed or invoiced by such Related Party on resale of such Licensed Products
to a third party purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&ldquo;Patent Rights&rdquo;</B> means, in each case to the extent owned and controlled by BIU: (a) the patent applications listed
in Exhibit B; (b) any patent or patent application that claims priority to and is a divisional, continuation, reissue, renewal,
reexamination, substitution or extension of any patent application identified in (a); (c) any patents issuing on any patent application
identified in (a) or (b), including any reissues, renewals, reexaminations, substitutions or extensions thereof; (d) any claim
of a continuation-in-part application or patent (including any reissues, renewals, reexaminations, substitutions or extensions
thereof) that is entitled to the priority date of, and is directed specifically to subject matter specifically described in, at
least one of the patents or patent applications identified in (a), (b) or (c); (e) any foreign counterpart (including PCTs) of
any patent or patent application identified in (a), (b) or (c) or of the claims identified in (d); and (f) any supplementary protection
certificates, pediatric exclusivity periods, any other patent term extensions and exclusivity periods and the like of any patents
and patent applications identified in (a) through (e);&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;Related
Party&rdquo; </B>means License and any Affiliate of Licensee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;Technology
Transfer Material&rdquo;</B> means the protocols, data and other results listed in Exhibit D hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;Territory&rdquo;</B>
means Europe, Asia, South America and Australia.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;Valid
Claim&rdquo;</B> means: (a) a claim of an issued and unexpired patent within the Patent Rights that has not been (i) held permanently
revoked, unenforceable, unpatentable or invalid by a decision of a court or governmental body of competent jurisdiction, unappealable
or unappealed within the time allowed for appeal, (ii) rendered unenforceable through disclaimer or otherwise, (iii) abandoned
or (iv) permanently lost through an interference or opposition proceeding without any right of appeal or review; or (b) a pending
claim of a pending patent application within the Patent Rights that (i) has been asserted and continues to be prosecuted in good
faith and (ii) has not been abandoned or finally rejected without the possibility of appeal or refilling.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-weight: bold">
    <TD STYLE="width: 7%; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>2.</B></FONT></td>
    <TD STYLE="font: bold 10 Times New Roman, Times, Serif; text-align: justify; width: 93%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>License.</B></FONT></td></tr>
</table>
<P STYLE="font: 10pt Courier; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 7%; font-size: 10pt; text-indent: 0in; text-align: justify">&nbsp;</td>
    <TD STYLE="width: 7%; font-size: 10pt; text-indent: 0in; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>2.1.</b></font></td>
    <TD STYLE="width: 86%; font-size: 10pt; text-indent: 0in; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>License Grants.</b> </font></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Subject
to the terms and conditions set forth in this Agreement, BIRAD hereby grants to Licensee an exclusive (except as set forth below),
worldwide, non-transferrable, royalty-bearing, license (without the right to sublicense) under BIU&rsquo;s interest in the Patent
Rights for the sole purpose of developing, manufacturing, using, offering for sale and selling Licensed Products solely within
the Territory; provided that BIRAD reserve the right, for itself, BIU and other not-for-profit research organizations to practice
and use the Patent Rights within the scope of the license set forth above solely for research, teaching and other educational purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Subject
to the terms and conditions set forth in this Agreement, BIRAD hereby grants to Licensee an exclusive, worldwide, non-transferrable,
royalty-bearing, license (without the right to sublicense) under BIU&rsquo;s interest in the Technology Transfer Material for the
sole purpose of practicing the Licensed Method solely for the purpose of developing, manufacturing, using, offering for sale and
selling Licensed Products solely within the Territory.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>
2.1.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>For clarity, no license is granted with respect to any
activities outside the Territory and no license is granted with respect to Covered Textiles for any use other than in
Licensed Products. Licensee shall not, and shall ensure that its Affiliates, contractors and distributors shall not: (a)
make, use, market nor sell Licensed Products outside the Territory; and (b) use or incorporate Covered Textiles in any
product that is not a Licensed Product.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Sublicense. </B>For clarity, Licensee shall not be entitled to grant licenses under the rights granted under Section 2.1 without
the prior written consent of BIRAD, which may be granted or withheld by BIRAD in its sole discretion. Licensee understands that
any such consent, if granted, will be conditioned upon the parties agreeing to the terms of compensation to be paid to BIRAD in
connection with such sublicense and other provisions protecting BIRAD&rsquo;s rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Affiliates
and Contractors.</B> The license granted to Licensee under Section 2.1 includes the right to have some or all of Licensee&rsquo;s
rights under Section 2.1 exercised or performed by one or more of Licensee&rsquo;s Affiliates and/or contractors on Licensee&rsquo;s
behalf for Licensee&rsquo;s benefit without such right being deemed a sublicense; provided, however, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>no
such Affiliate or contractor shall be entitled to grant, directly or indirectly, to any third party any right of whatever nature
under, or with respect to, or permitting any use or exploitation of, any of the Patent Rights or Technology Transfer Material,
including any right to develop, manufacture, market, sell or provide Licensed Products; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>any
act or omission taken or made by an Affiliate or contractor of Licensee under this Agreement will be deemed an act or omission
by Licensee under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.4</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-weight: normal">No
Other Grant of Rights. Except for the licenses expressly granted in this Agreement, nothing in this Agreement shall be construed
to confer any ownership interest, license or other rights upon Licensee by implication, estoppel or otherwise as to any technology,
intellectual property rights, products or materials of BIRAD, BIU or any other entity, regardless of whether such technology,
intellectual property rights, products or materials are dominant, subordinate or otherwise related to any Patent Rigths or Technology
Transfer Material.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: bold 10 Times New Roman, Times, Serif">
    <TD STYLE="width: 7%; font: bold 10 Times New Roman, Times, Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>3.</b></font></td>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; width: 93%"><FONT STYLE="font-size: 10pt"><B>Development
    and Commercialization.</B></FONT></td></tr>
</table>
<P STYLE="font: 10pt Courier; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diligence.<FONT STYLE="font-weight: normal">
Licensee, alone and/or through its Affiliates, shall use commercially reasonable efforts, including funding consistent therewith:
<FONT STYLE="color: black">(a) to develop Licensed Products; (b) to introduce Licensed Products into the commercial market; and
(c) to market Licensed Products following such introduction into the market. </FONT>In addition and without limiting the foregoing,
Licensee, by itself and/or through its Affiliates, shall achieve each of the Development Milestones within the time periods specified
in Exhibit A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reporting.<FONT STYLE="font-weight: normal">
Within sixty (60) days after the end of each calendar year, Licensee shall furnish BIRAD with a written report summarizing its
and its Affiliates&rsquo; efforts during the prior year to develop and commercialize Licensed Products, including without limitation:
(a) research and development activities; (b) commercialization efforts; and (c) marketing efforts. Each report shall contain a
sufficient level of detail for BIRAD to assess whether Licensee is in compliance with its obligations under Section 3.1 and a discussion
of intended efforts for the then current year.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal"></FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Failure
to Meet Development Milestone; Opportunity to Cure.<FONT STYLE="font-weight: normal"> If Licensee believes that it will not achieve
a Development Milestone, it may notify BIRAD in writing in advance of the relevant deadline. Licensee shall include with such notice
(a) a reasonable explanation of the reasons for such failure (and lack of finances shall not constitute reasonable basis for such
failure) (&ldquo;Explanation&rdquo;) and (b) a reasonable, detailed, written plan for promptly achieving a reasonable extended
and/or amended milestone (&ldquo;Plan&rdquo;). If Licensee so notifies BIRAD, but fails to provide BIRAD with both an Explanation
and Plan, then the provisions of Section 10.2.3.1 shall apply if Licensee in fact fails to meet the Development Milestone. If Licensee
so notifies BIRAD and provides BIRAD with an Explanation and Plan, both of which are acceptable to BIRAD in its reasonable discretion,
then Exhibit A shall be amended automatically to incorporate the extended and/or amended milestone set forth in the Plan. If Licensee
so notifies BIRAD and provides BIRAD with an Explanation and Plan, but the Explanation is not reasonable to BIRAD in its reasonable
discretion (e.g. Licensee asserts lack of finances or development preference for a non-Licensed Product), then the deadline for
the relevant milestone shall remain unchanged and the provisions of Section 10.2.3.1 shall apply if Licensee in fact fails to meet
such milestone. If Licensee so notifies BIRAD and provides BIRAD with an Explanation and Plan, but the Plan is not acceptable to
BIRAD in its reasonable discretion, then BIRAD shall explain to Licensee why the Plan is not acceptable and provide Licensee with
suggestions for an acceptable Plan. Licensee shall have one opportunity to provide BIRAD with a reasonable Plan within ninety (90)
days, during which time BIRAD agrees to work with Licensee in its effort to develop a reasonable Plan. If, within such ninety (90)
days, Licensee provides BIRAD with a reasonable Plan, then Exhibit A shall be amended automatically to incorporate the extended
and/or amended milestone set forth in the Plan. If, within such ninety (90) days, Licensee fails to provide a reasonable Plan,
then Licensee shall have an additional thirty (30) days or until the original deadline of the relevant Development Milestone, whichever
is later, to meet such milestone. Licensee&rsquo;s failure to do so shall constitute a material breach of this Agreement and BIRAD
shall have the right to terminate this Agreement forthwith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-weight: bold">
    <TD STYLE="width: 7%; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>4.</B></FONT></td>
    <TD STYLE="width: 93%; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Consideration
    for Grant of License</B></FONT></td></tr>
</table>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;License
Issuance Fee.</B> Within thirty (30) days of the execution of this Agreement, Licensee shall pay BIRAD a non-refundable license
issuance fee of Thirty Five Thousand US Dollars ($35,000).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Annual
Fee.</B> Licensee shall pay BIRAD annual license maintenance fee of Twenty Thousand US Dollars ($20,000) per year. The first such
annual fee will be due and payable on the first anniversary of the Effective Date and the others will be due on each anniversary
thereafter during the term of this Agreement. Each annual license maintenance fee shall be creditable against any royalty amounts
payable under Section 4.3 below with respect to Licensed Products sold in the same calendar year that such annual license maintenance
fee was due.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>4.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Royalty
on Net Sales. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>4.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Royalty
Rate. </B>Licensee shall pay BIRAD an amount equal to three percent (3%) of all Net Sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>4.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Royalty
Term. </B>The royalties set forth above will be due until the later of: (a) the expiration of the last to expire Patent Rights;
and (b)<B> </B>until fifteen (15) years have passed from the date of the First Commercial Sale.<B><I> </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B><I>&nbsp;</I></B></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;&nbsp;</I></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-weight: bold">
    <TD STYLE="width: 7%; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>5.</B></FONT></td>
    <TD STYLE="width: 93%; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Reports;
    Payments; Records.</B></FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-weight: bold">
    <TD STYLE="width: 7%; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><B>&nbsp;</B></td>
    <TD STYLE="width: 8%; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>5.1.</B></FONT></td>
    <TD STYLE="width: 85%; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Reports
    and Payments.</B></FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reports.
<FONT STYLE="font-weight: normal">Within thirty (30) days after the conclusion of each Calendar Quarter commencing with the first
Calendar Quarter in which Net Sales are generated, Licensee shall deliver to BIRAD a report containing the following information
(in each case, with a Licensed Product-by-Licensed Product breakdown): </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">5.1.1.1.&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-weight: normal">if
there was a First Commercial Sale of a Licensed Product in such Calendar Quarter, the name of the country and the date of the First
Commercial Sale;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">5.1.1.2.<FONT STYLE="font-weight: normal">
the number of units of Licensed Products sold by Related Parties for the applicable Calendar Quarter;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">5.1.1.3 <FONT STYLE="font-weight: normal">the
gross amount billed or invoiced for Licensed Products sold, leased, otherwise transferred or provided by Related Parties during
the applicable Calendar Quarter; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">5.1.1.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-weight: normal">a
calculation of Net Sales for the applicable Calendar Quarter, including an itemized listing of applicable deductions; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">5.1.1.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-weight: normal">a
calculation of amount payable to BIRAD for the applicable Calendar Quarter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Each such report
shall be certified on behalf of Licensee by a senior officer of Licensee as true, correct and complete in all material respects.
If no amounts are due to BIRAD for a particular Calendar Quarter, the report shall so state.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment.
<FONT STYLE="font-weight: normal">Within thirty (30) days after the end of each Calendar Quarter, Licensee shall pay BIRAD all
amounts due for the applicable Calendar Quarter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment
Currency. <FONT STYLE="font-weight: normal">All payments due under this Agreement will be paid in New Israeli Shekels. Conversion
of foreign currency to New Israeli Shekels will be made at the conversion rate published by the Bank of Israel for the last working
day of the applicable Calendar Quarter. Such payments will be without deduction of exchange, collection or other charges.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Records.
<FONT STYLE="font-weight: normal">Licensee shall maintain, and shall cause its Affiliates to maintain, complete and accurate records
of Licensed Products that are made, used, sold, leased, otherwise transferred or provided under this Agreement and any amounts
payable to BIRAD in relation to such Licensed Products, which records shall contain sufficient information to permit BIRAD to confirm
the accuracy of any reports or notifications delivered to BIRAD under Section 5.1. Licensee and the relevant Affiliates shall retain
such records relating to a given Calendar Quarter for at least five (5) years after the conclusion of that Calendar Quarter, during
which time BIRAD shall have the right, at its expense, to cause an independent, certified public accountant (or, in the event of
a non-financial audit, other appropriate auditor) to inspect such records during normal business hours for the purposes of verifying
the accuracy of any reports and payments delivered under this Agreement and Licensee&rsquo;s compliance with the terms hereof.
Such accountant or other auditor, as applicable, shall not disclose to BIRAD any information other than information relating to
the accuracy of reports and payments delivered under this Agreement. The parties shall reconcile any underpayment or overpayment
within thirty (30) days after the accountant delivers the results of the audit. In the event that any audit performed under this
Section 5.2 reveals an underpayment in excess of five percent (5%) in any calendar year, the audited entity shall bear the full
cost of such audit. BIRAD may exercise its rights under this Section 5.2 only once every year per audited entity and only with
reasonable prior notice to the audited entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Late
Payments. <FONT STYLE="font-weight: normal">Any payments by Licensee that are not paid on or before the date such payments are
due under this Agreement shall bear interest at the lower of (a) one and one half percent (1.5%) per month and (b) the maximum
rate allowed by law. Interest shall accrue beginning on the first day following the due date for payment and shall be compounded
quarterly. Payment of such interest by Licensee shall not limit, in any way, BIRAD&rsquo;s right to exercise any other remedies
BIRAD may have as a consequence of the lateness of any payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment
Method<FONT STYLE="font-weight: normal">. Each payment due to BIRAD under this Agreement shall be paid by check or wire transfer
of funds to BIRAD&rsquo;s account in accordance with written instructions provided by BIRAD. If made by wire transfer, such payments
shall be marked so as to refer to this Agreement.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;VAT;
Withholding and Similar Taxes. <FONT STYLE="font-weight: normal">All amounts to be paid to BIRAD pursuant to this Agreement are
exclusive of Value Added Tax. Licensee shall add value added tax, to the extent required by applicable law, to all such amounts.
All amounts to be paid to BIRAD pursuant to this Agreement shall be without deduction of exchange, collection, or other charges,
and, specifically, without deduction of withholding or similar taxes or other government imposed fees or taxes. Notwithstanding
the foregoing, if Licensee is required to withhold any amounts payable hereunder in accordance with the requirement of Israeli
incom tax law and BIRAD is unable to present Licensee with proof of exemption from such withholding, such amount will be deducted
from the payment to be made by Licensee and remitted to the Israeli income tax authority for the benefit of BIRAD. Licensee will
withhold only such amounts as are required to be withheld by Israeli income tax law. Licensee shall submit to BIRAD originals of
the remittance voucher and the official receipt evidencing the payment of the corresponding taxes with the applicable royalty report.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-weight: bold">
    <TD STYLE="width: 7%; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>6.</B></FONT></td>
    <TD STYLE="width: 93%; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Patent
    Filing, Prosecution and Maintenance.</B></FONT></td></tr>
</table>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Control.<FONT STYLE="font-weight: normal">
BIRAD shall be responsible for the preparation, filing, prosecution, protection and maintenance of all Patent Rights, using independent
patent counsel reasonably acceptable to Licensee. BIRAD shall: (a) instruct such patent counsel to furnish the Licensee with copies
of all correspondence relating to the Patent Rights from the United States Patent and Trademark Office (USPTO) and any other patent
office, as well as copies of all proposed responses to such correspondence in time for Licensee to review and comment on each such
response; (b) give Licensee an opportunity to review the text of each patent application before filing; (c) consult with Licensee
with respect thereto; (d) supply Licensee with a copy of the application as filed, together with notice of its filing date and
serial number; and (e) keep Licensee advised of the status of actual and prospective patent filings. BIRAD shall give Licensee
the opportunity to provide comments on and make requests of BIRAD concerning the preparation, filing, prosecution, protection and
maintenance of the Patent Rights, and shall consider such comments and requests in good faith; however, final decision-making authority
shall vest in BIRAD. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">6.2.</TD><TD STYLE="text-align: justify">Expenses<FONT STYLE="font-weight: normal">.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-weight: normal">Subject
to Section 6.3 below, Licensee shall reimburse BIRAD for all documented, out-of-pocket expenses incurred by BIRAD pursuant to this
Section 6 within thirty (30) days after the date of each invoice from BIRAD for such expenses. In addition, Licensee shall reimburse
BIRAD for all documented, out-of-pocket expenses incurred by BIRAD prior to the execution of this Agreement with respect to the
preparation, filing, prosecution, protection and maintenance of Patent Rights within thirty (30) days after the date of each invoice
from BIRAD for such expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-weight: normal">If
BIRAD enters into a license with a third party with respect to any of the Patent Rights, BIRAD will proportionately reduce Licensee&rsquo;s
share of such expenses with respect to the Patent Rights going forward. In addition, BIRAD shall use commercially reasonable efforts
to cause each new licensee of the Patent Rights to agree to pay a pro-rata portion of expenses already reimbursed by Licensee in
connection with the Patent Rights, taking into consideration the scope and type (e.g., field, exclusive vs. non-exclusive, etc.)
of such new license. BIRAD will reimburse Licensee for a pro rata share of such expenses already paid by Licensee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: black"><B>6.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abandonment.
</B>If</FONT> Licensee decides that it does not wish to pay for the preparation, filing, prosecution, protection or maintenance
of any Patent Rights in a particular country (&ldquo;Abandoned Patent Rights&rdquo;), Licensee shall provide BIRAD with prompt
written notice of such election. Upon receipt of such notice by BIRAD, Licensee shall be released from its obligation to reimburse
BIRAD for the expenses incurred thereafter as to such Abandoned Patent Rights; provided, however, that expenses authorized prior
to the receipt by BIRAD of such notice shall be deemed incurred prior to the notice. In the event of Licensee&rsquo;s abandonment
of any Patent Rights, any license granted by BIRAD to Licensee hereunder with respect to such Abandoned Patent Rights will terminate,
and Licensee will have no rights whatsoever to exploit such Abandoned Patent Rights. BIRAD will then be free, without further notice
or obligation to Licensee, to grant rights in and to such Abandoned Patent Rights to third parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Marking.
<FONT STYLE="font-weight: normal">Licensee shall, and shall cause its Affiliates to, mark all License Products sold or otherwise
disposed of in such a manner as to conform with the patent laws and practice of the country to which such products are shipped
or in which such products are sold for <FONT STYLE="font-style: normal; color: Black">purposes of ensuring maximum enforceability
of Patent Rights in such country.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-weight: bold">
    <TD STYLE="width: 7%; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>7.</B></FONT></td>
    <TD STYLE="width: 93%; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Enforcement
    of Patent Rights. </B></FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.3pt"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notice.<FONT STYLE="font-weight: normal">
In the event either party becomes aware of any possible or actual infringement of any Patent Rights with respect to Licensed Products
(an &ldquo;Infringement&rdquo;), that party shall promptly notify the other party and provide it with details regarding such Infringement.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Suit
by Licensee.<FONT STYLE="font-weight: normal"> Licensee shall have the first right, but not the obligation, to take action in the
prosecution, prevention, or termination of any Infringement. <FONT STYLE="color: black">Before Licensee commences an action with
respect to any Infringement, Licensee shall consider in good faith the views of BIRAD and potential effects on the public interest
in making its decision whether to sue. </FONT>Should Licensee elect to bring suit against an Infringer, <FONT STYLE="color: black">Licensee
shall keep BIRAD reasonably informed of the progress of the action and shall give BIRAD a reasonable opportunity in advance to
consult with Licensee and offer its views about major decisions affecting the litigation. Licensee shall give careful consideration
to those views, but shall have the right to control the action; provided, however, that if Licensee fails to defend in good faith
the validity and/or enforceability of the Patent Rights in the action or, or if Licensee&rsquo;s license to the Patent Rights in
the suit terminates, BIRAD may elect to take control of the action pursuant to Section 7.3</FONT>. Should Licensee elect to bring
suit against an Infringer and BIRAD is joined as party plaintiff in any such suit, BIRAD shall have the right to approve the counsel
selected by Licensee to represent Licensee and BIRAD, such approval not to be unreasonably withheld. The expenses of such suit
or suits that Licensee elects to bring, including any expenses of BIRAD incurred in conjunction with the prosecution of such suits
or the settlement thereof, shall be paid for entirely by Licensee and Licensee shall hold BIRAD free, clear and harmless from and
against any and all costs of such litigation, including attorney&rsquo;s fees. Licensee shall not compromise or settle such litigation
without the prior written consent of BIRAD, which consent shall not be unreasonably withheld or delayed. In the event Licensee
exercises its right to sue pursuant to this Section 7.2, it shall first reimburse itself out of any sums recovered in such suit
or in settlement thereof for all costs and expenses of every kind and character, including reasonable attorney&rsquo;s fees, necessarily
incurred in the prosecution of any such suit. If, after such reimbursement, any funds shall remain from said recovery, then BIRAD
shall receive an amount equal to twenty five percent (25%) of such funds and the remaining seventy-five percent (75%) of such funds
shall be retained by Licensee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Suit
by BIRAD.<FONT STYLE="font-weight: normal"> If Licensee does not take action in the prosecution, prevention, or termination of
any Infringement pursuant to Section 7.2 above, and has not commenced negotiations with the infringer for the discontinuance of
said Infringement, within ninety (90) days after receipt of notice to Licensee by BIRAD of the existence of an Infringement, BIRAD
may elect to do so. Should BIRAD elect to bring suit against an infringer and Licensee is joined as party plaintiff in any such
suit, Licensee shall have the right to approve the counsel selected by BIRAD to represent BIRAD and Licensee, such approval not
to be unreasonably withheld. The expenses of such suit or suits that BIRAD elects to bring, including any expenses of Licensee
incurred in conjunction with the prosecution of such suits or the settlement thereof, shall be paid for entirely by BIRAD and BIRAD
shall hold Licensee free, clear and harmless from and against any and all costs of such litigation, including attorney&rsquo;s
fees. BIRAD shall not compromise or settle such litigation without the prior written consent of Licensee, which consent shall not
be unreasonably withheld or delayed. In the event BIRAD exercises its right to sue pursuant to this Section 7.3, it shall first
reimburse itself out of any sums recovered in such suit or in settlement thereof for all costs and expenses of every kind and character,
including reasonable attorney&rsquo;s fees, necessarily incurred in the prosecution of any such suit. If, after such reimbursement,
any funds shall remain from said recovery, then Licensee shall receive an amount equal to twenty-five percent (25%) of such funds
and the remaining seventy-five percent (75%) of such funds shall be retained by BIRAD.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Own
Counsel.<FONT STYLE="font-weight: normal"> Each party shall always have the right to be represented by counsel of its own selection
and at its own expense in any suit instituted under this Section 7 by the other party for Infringement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cooperation.<FONT STYLE="font-weight: normal">
Each party agrees to cooperate fully in any action under this Section 7 that is controlled by the other party, provided that the
controlling party reimburses the cooperating party promptly for any costs and expenses incurred by the cooperating party in connection
with providing such assistance. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Standing.<FONT STYLE="font-weight: normal">
If a party lacks standing and the other party has standing to bring any such suit, action or proceeding, then such other party
shall do so at the request of and at the expense of the party that lacks standing. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: black">7.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Declaratory<FONT STYLE="color: black">
Judgment.<FONT STYLE="font-weight: normal"> If a declaratory judgment action is brought naming a Related Party as a defendant and
alleging invalidity or unenforceability of any claims within the Patent Rights, Licensee shall promptly notify BIRAD in writing
and BIRAD may elect, upon written notice to Licensee within thirty (30) days after BIRAD receives notice of the commencement of
such action, to take over the sole defense of the invalidity and/or unenforceability aspect of the action at its own expense.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-weight: bold">
    <TD STYLE="width: 7%; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>8.</B></FONT></td>
    <TD STYLE="width: 93%; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Warranties;
    Limitation of Liability.</B></FONT></td></tr>
</table>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compliance
with Law.<FONT STYLE="font-weight: normal"> Licensee represents and warrants that it will comply, and will ensure that its Affiliates
comply, with all local, state, and international laws and regulations relating to the development, manufacture, use, sale and importation
of Licensed Products. Without limiting the foregoing, Licensee represents and warrants that it will comply, and will ensure that
its Affiliates comply, with all applicable export control laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top; font-weight: bold">
    <TD STYLE="width: 0.5in; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><B>&nbsp;</B></td>
    <TD STYLE="width: 0.5in; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>8.2.</B></FONT></td>
    <TD STYLE="font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Disclaimer
    of Other Warranties.</B></FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-transform: uppercase">8.2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-weight: normal">Nothing
contained herein shall be deemed to be a warranty by BIRAD that it can or will be able to obtain patents on patent applications
included in the Patent Rights, or that any of the Patent Rights will afford adequate or commercially worthwhile protection.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-transform: uppercase">8.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-weight: normal">BIRAD
AND BIU MAKE NO WARRANTIES WHATSOEVER AS TO THE COMMERCIAL OR SCIENTIFIC VALUE OF THE PATENT RIGHTS OR TECHNOLOGY TRANSFER MATERIALS.
BIRAD AND BIU MAKE NO REPRESENTATION THAT THE PRACTICE OF THE PATENT RIGHTS OR USE OF THE TECHNOLOGY TRANSFER MATERIALS OR THE
DEVELOPMENT, MANUFACTURE, USE, SALE OR IMPORTATION OF ANY LICENSED PRODUCT, OR ANY ELEMENT THEREOF, WILL NOT INFRINGE THE PATENT
OR PROPRIETARY RIGHTS OF ANY THIRD PARTY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.2.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-weight: normal">EXCEPT
AS OTHERWISE EXPRESSLY PROVIDED IN THIS AGREEMENT, NEITHER PARTY MAKES ANY WARRANTY WITH RESPECT TO ANY TECHNOLOGY, PATENTS, GOODS,
SERVICES, RIGHTS OR OTHER SUBJECT MATTER OF THIS AGREEMENT AND HEREBY DISCLAIMS WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR
PURPOSE AND NONINFRINGEMENT WITH RESPECT TO ANY AND ALL OF THE FOREGOING.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top; font-weight: bold">
    <TD STYLE="width: 0.5in; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><B>&nbsp;</B></td>
    <TD STYLE="width: 0.5in; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>8.3</B></FONT></td>
    <TD STYLE="font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Limitation
    of Liability.&nbsp;&nbsp;</B></FONT></td></tr>
</table>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-weight: normal">Except
with respect to matters for which Licensee is obligated to indemnify Indemnitees under Section 9, neither party will be liable
to the other with respect to any subject matter of this Agreement under any contract, negligence, strict liability or other legal
or equitable theory for (a) any indirect, incidental, consequential or punitive damages or lost profits or (b) cost of procurement
of substitute goods, technology or services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-weight: normal">BIRAD&rsquo;s
aggregate liability for all damages of any kind arising out of or relating to this Agreement or its subject matter shall not exceed
the amounts paid to BIRAD under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-weight: bold">
    <TD STYLE="width: 7%; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>9.</B></FONT></td>
    <TD STYLE="width: 93%; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Indemnification.</B></FONT></td></tr>
</table>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indemnity.
<FONT STYLE="font-weight: normal">Licensee shall indemnify, defend and hold harmless BIRAD and BIU and their respective current
and former directors, governing board members, trustees, officers, faculty, professional staff, employees, students, and agents
and their respective successors, heirs and assigns (collectively, the &ldquo;Indemnitees&rdquo;) from and against any claim, liability,
cost, expense, damage, deficiency, loss or obligation or any kind or nature (including, without limitation, reasonable attorney&rsquo;s
fees and other costs and expenses of litigation) (collectively, &ldquo;Claims&rdquo;), based upon, arising out of, or otherwise
relating to this Agreement, including without limitation any cause of action relating to product liability concerning any product,
process, or service made, used or sold pursuant to any right or license granted under this Agreement. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Procedures.<FONT STYLE="font-weight: normal">
If any Indemnitee receives notice of any Claim, such Indemnitee shall, as promptly as is reasonably possible, give Licensee notice
of such Claim; provided, however, that failure to give such notice promptly shall only relieve Licensee of any indemnification
obligation it may have hereunder to the extent such failure diminishes the ability of Licensee to respond to or to defend the Indemnitee
against such Claim. BIRAD and Licensee shall consult and cooperate with each other regarding the response to and the defense of
any such Claim and Licensee shall, upon its acknowledgment in writing of its obligation to indemnify the Indemnitee, be entitled
to and shall assume the defense or represent the interests of the Indemnitee in respect of such Claim, that shall include the right
to select and direct legal counsel and other consultants to appear in proceedings on behalf of the Indemnitee and to propose, accept
or reject offers of settlement, all at its sole cost; provided, however, that no such settlement shall be made without the written
consent of the Indemnitee, such consent not to be unreasonably withheld. Nothing herein shall prevent the Indemnitee from retaining
its own counsel and participating in its own defense at its own cost and expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insurance.<FONT STYLE="font-weight: normal">
Beginning at the time any Licensed Product is being commercially distributed, sold or (in the case of services) provided by or
on behalf of Licensee, or an Affiliate of Licensee, Licensee shall, at its sole cost and expense, procure and maintain insurance
that is reasonably adequate to fulfill any potential obligation to the Indemnitees under this Section 9, taking into consideration,
among other things, the nature of the products commercialized. Without limiting the foregoing, beginning at the time any Licensed
Product is being sold, leased, otherwise transferred or provided, such insurance shall include commercial liability insurance in
amounts standard in the industry.</FONT> <FONT STYLE="font-weight: normal">Such insurance shall be obtained from a reputable insurance
company. BIRAD shall be added as co-insured parties under such insurance policy. Licensee hereby undertakes to comply punctually
with all obligations imposed upon it under such policy(ies), including without limitation the obligation to pay in full and punctually
all premiums and other payments due under such policy(ies). Licensee shall provide BIRAD, upon request, with written evidence of
such insurance. Licensee shall continue to maintain such insurance after the expiration or termination of this Agreement during
any period in which any Related Party continues to make, use, or sell Licensed Products, and thereafter for a period of seven (7)
years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-weight: bold">
    <TD STYLE="width: 7%; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>10.</B></FONT></td>
    <TD STYLE="width: 93%; font: bold 10pt Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Term
    and Termination.</B></FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Term.<FONT STYLE="font-weight: normal">
The term of this Agreement shall commence on the Effective Date and, unless earlier terminated as provided in this Section 10,
shall continue in full force and effect until the</FONT><I> </I><FONT STYLE="font-weight: normal">last-to-expire period during
which Licensee is obligated to pay royalties to BIRAD under Section 4.3. Following the expiration of this Agreement pursuant to
this Section 10.1 (and provided the Agreement has not been earlier terminated pursuant to any of the provisions of Section 10.2,
in which case the provisions of Section 10.3 will apply), the licenses granted to Licensee under Section 2.1 with respect to the
Technology Transfer Material shall become fully-paid up and non-exclusive license.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-weight: bold">
    <TD STYLE="width: 7%; font-family: Courier New, Courier, Monospace; font-weight: bold; text-align: justify"><B>&nbsp;</B></td>
    <TD STYLE="width: 8%; font-family: Courier New, Courier, Monospace; font-weight: bold; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>10.2.</B></FONT></td>
    <TD STYLE="width: 85%; font-family: Courier New, Courier, Monospace; font-weight: bold; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Termination.</B></FONT></td></tr>
</table>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Termination
Without Cause. <FONT STYLE="font-weight: normal">Licensee may terminate this Agreement upon sixty (60) days prior written notice
to BIRAD.<I> </I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Termination
for Patent Challenge. <FONT STYLE="font-weight: normal">BIRAD may terminate this Agreement immediately upon written notice to Licensee
if Licensee commences an action in which it challenges the validity, enforceability or scope of any of the Patent Rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-weight: bold">
    <TD STYLE="width: 14%; font-family: Courier New, Courier, Monospace; font-weight: bold; text-align: justify"><B>&nbsp;</B></td>
    <TD STYLE="width: 9%; font-family: Courier New, Courier, Monospace; font-weight: bold; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>10.2.3.</B></FONT></td>
    <TD STYLE="width: 77%; font-family: Courier New, Courier, Monospace; font-weight: bold; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Termination
    for Default.&nbsp;&nbsp;</B></FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">10.2.3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-weight: normal">In
the event that either party commits a material breach of its obligations under this Agreement and fails to cure that breach within
thirty (30) days after receiving written notice thereof, the other party may terminate this Agreement immediately upon written
notice to the party in breach.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">10.2.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-weight: normal">If
Licensee defaults in its obligations under Section 9.3 to procure and maintain insurance, then BIRAD may terminate this Agreement
immediately without notice or additional waiting period. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">10.2.3.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-weight: normal">BIRAD
may terminate this Agreement in accordance with the provisions of Section 3.4.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.2.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bankruptcy.
<FONT STYLE="font-weight: normal">BIRAD may terminate this Agreement upon notice to Licensee if Licensee becomes insolvent, is
adjudged bankrupt, applies for judicial or extra-judicial settlement with its creditors, makes an assignment for the benefit of
its creditors, voluntarily files for bankruptcy or has a receiver or trustee (or the like) in bankruptcy appointed by reason of
its insolvency, or in the event an involuntary bankruptcy action is filed against Licensee and not dismissed within ninety (90)
days, or if the other party becomes the subject of liquidation or dissolution proceedings or otherwise discontinues business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-weight: bold">
    <TD STYLE="width: 7%; font-family: Courier New, Courier, Monospace; font-weight: bold; text-align: justify"><B>&nbsp;</B></td>
    <TD STYLE="width: 8%; font-family: Courier New, Courier, Monospace; font-weight: bold; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>10.3.</B></FONT></td>
    <TD STYLE="width: 85%; font-family: Courier New, Courier, Monospace; font-weight: bold; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Effect
    of Termination.&nbsp;&nbsp;</B></FONT></td></tr>
</table>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt">10.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Termination
of Rights.<FONT STYLE="font-weight: normal"> Upon termination of this Agreement by either party pursuant to any of the provisions
of Section 10.2, the rights and licenses granted to Licensee under Section 2 shall terminate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt">10.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accruing
Obligations. <FONT STYLE="font-weight: normal">Termination or expiration of this Agreement shall not relieve the parties of obligations
accruing prior to such termination or expiration, including obligations to pay amounts accruing hereunder up to the date of termination
or expiration. After the date of termination or expiration (except in the case of termination by BIRAD in accordance with any of
the provisions of Section 10.2.2 or 10.2.3), Licensee and its Affiliates (a) may sell Licensed Products then in stock and (b) may
complete the production of Licensed Products then in the process of production and sell the same; provided that, in the case of
both (a) and (b), Licensee shall pay the applicable royalties and payments to BIRAD in accordance with Section 4.3, provide reports
and audit rights to BIRAD pursuant to Section 5 and maintain insurance in accordance with the requirements of Section 9.3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.3.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transfer
of IP. </B>If Licensee terminates this Agreement pursuant to Section 10.2.1 or BIRAD terminates this Agreement pursuant to any
of the provisions of Section 10.2, Licensee shall promptly deliver and assign to BIRAD all intellectual property, inventions, conceptions,
compositions, materials, methods, processes, data, information, records, results, studies and analyses, discovered or acquired
by, or on behalf of Licensee and its Affiliates which relate directly to actual or potential Licensed Products.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Survival.<FONT STYLE="font-weight: normal">
The parties&rsquo; respective rights, obligations and duties under Sections 5.1 (with respect to sales made prior to termination
or in accordance with Section 10.3.2), 5.2, 5.3, 5.4, 5.5, 5.6, 8.1, 8.3, 9, 10.3, 11, 12.1 and 12.4 as well as any rights, obligations
and duties which by their nature extend beyond the expiration or termination of this Agreement, shall survive any expiration or
termination of this Agreement. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-weight: bold">
    <TD STYLE="width: 7%; font-family: Courier New, Courier, Monospace; font-weight: bold; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>11.</B></FONT></td>
    <TD STYLE="width: 93%; font-family: Courier New, Courier, Monospace; font-weight: bold; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Confidential
    Information</B></FONT></td></tr>
</table>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BIRAD
Confidential Information. <FONT STYLE="font-weight: normal">Licensee agrees that, without the prior written consent of BIRAD for
a period of seven (7) years from date of disclosure, it will keep confidential, and not disclose or use BIRAD Confidential Information
(as defined below) other than for the purposes of this Agreement. Licensee shall treat such BIRAD Confidential Information with
the same degree of confidentiality as it keeps its own confidential information, but in all events no less than a reasonable degree
of confidentiality. Licensee may disclose BIRAD Confidential Information only to employees, consultants and contractors of Licensee
who have a &ldquo;need to know&rdquo; such information in order to enable Licensee to exercise its rights or fulfill its obligations
under this Agreement and are legally bound by agreements which impose confidentiality and non-use obligations comparable to those
set forth in this Agreement. For purposes of this Agreement, &ldquo;BIRAD Confidential Information&rdquo; means any unpublished
Patent Rights and any information within the Technology Transfer Material or that is disclosed to Licensee that is designated as
confidential or which otherwise should reasonably be construed under the circumstances as being confidential, except to the extent
such information: (i) was known to Licensee at the time it was disclosed, other than by previous disclosure by or on behalf of
BIRAD or BIU, as evidenced by Licensee&rsquo;s written records at the time of disclosure; (ii) is at the time of disclosure or
later becomes publicly known under circumstances involving no breach of this Agreement; (iii) is lawfully and in good faith made
available to Licensee by a third party who is not subject to obligations of confidentiality to BIRAD nor BIU with respect to such
information; or (iv) is independently developed by Licensee without the use of or reference to BIRAD Confidential Information,
as demonstrated by documentary evidence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Licensee
Confidential Information. <FONT STYLE="font-weight: normal">BIRAD agrees that, without the prior written consent of Licensee for
a period of seven (7) years from date of disclosure, it will keep confidential, and not disclose or use Licensee Confidential Information
(as defined below) other than for the purposes of this Agreement. BIRAD shall treat such Licensee Confidential Information with
the same degree of confidentiality as it keeps its own confidential information, but in all events no less than a reasonable degree
of confidentiality. BIRAD may disclose Licensee Confidential Information only to employees and consultants of and BIU who have
a &ldquo;need to know&rdquo; such information in order to enable BIRAD to exercise its rights under this Agreement and are legally
bound by agreements which impose confidentiality and non-use obligations comparable to those set forth in this Agreement. For purposes
of this Agreement, &ldquo;Licensee Confidential Information&rdquo; means information contained in reports delivered by Licensee
to BIRAD pursuant to Section 3 or 5, except to the extent such information: (i) was known to BIRAD or BIU at the time it was disclosed,
other than by previous disclosure by or on behalf of Licensee, as evidenced by BIRAD&rsquo;s or BIU&rsquo;s written records at
the time of disclosure; (ii) is at the time of disclosure or later becomes publicly known under circumstances involving no breach
of this Agreement; (iii) is lawfully and in good faith made available to BIRAD or BIU by a third party who is not subject to obligations
of confidentiality to Licensee with respect to such information; or (iv) is independently developed by BIRAD or BIU without the
use of or reference to Licensee Confidential Information, as demonstrated by documentary evidence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font-weight: bold">
    <TD STYLE="width: 7%; font-family: Courier New, Courier, Monospace; font-weight: bold; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>12.</B></FONT></td>
    <TD STYLE="width: 93%; font-family: Courier New, Courier, Monospace; font-weight: bold; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Miscellaneous.</B></FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Use
of Name.<FONT STYLE="font-weight: normal"> Licensee shall not, and shall ensure that its Affiliates shall not, use the name or
insignia of BIU or BIRAD or the name of any of BIU&rsquo;s or BIRAD&rsquo;s officers, faculty, employees, other researchers or
students, or any adaptation of such names, in any advertising, promotional or sales literature, including without limitation any
press release or any document employed to obtain funds, without the prior written approval of BIRAD. </FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Entire
Agreement.<FONT STYLE="font-weight: normal"> This Agreement is the sole agreement with respect to the subject matter hereof and
except as expressly set forth herein, supersedes all other agreements and understandings between the parties with respect to the
same.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notices.<FONT STYLE="font-weight: normal">
Unless otherwise specifically provided, all notices required or permitted by this Agreement shall be in writing and may be delivered
personally, or may be sent by facsimile, overnight delivery or certified mail, return receipt requested, to the following addresses,
unless the parties are subsequently notified of any change of address in accordance with this Section 12.3:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 35%; padding-left: 1in; font-family: Courier New, Courier, Monospace"><font style="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;If to Licensee:</font></td>
    <TD STYLE="width: 65%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">T.A.B. Anti Bacterial Textiles Ltd</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ga'aton avenue 19,</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nahariya, Israel</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Attn: Chief Executive Officer</P></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-left: 1in; font-family: Courier New, Courier, Monospace">&nbsp;</td>
    <TD STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-left: 1in; font-family: Courier New, Courier, Monospace">&nbsp;&nbsp;<font style="font: 10pt Times New Roman, Times, Serif">If to BIRAD:</font></td>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bar Ilan Research and Development Company Ltd.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bar Ilan University</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ramat Gan, Israel</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Attn: Director of Business Development</P></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Any notice shall be deemed
to have been received as follows: (a) by personal delivery, upon receipt; (b) by facsimile or overnight delivery, one business
day after transmission or dispatch; (c) by certified mail, as evidenced by the return receipt. If notice is sent by facsimile,
a confirming copy of the same shall be sent by mail to the same address.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Governing
Law and Jurisdiction<FONT STYLE="font-weight: normal">. This Agreement will be governed by, and construed in accordance with, the
laws Israel, without giving effect to any choice or conflict of law provision, except that questions affecting the construction
and effect of any patent shall be determined by the law of the country in which the patent shall have been granted. The parties
hereby agree that the competent court in Tel Aviv Israel shall have sole jurisdiction over any and all matters arising from this
Agreement, except that BIRAD may bring suit against Licensee in any other jurisdiction outside Israel in which Licensee has assets
or a place of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Binding
Effect.<FONT STYLE="font-weight: normal"> This Agreement shall be binding upon and inure to the benefit of the parties and their
respective legal representatives, successors and permitted assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Headings.<FONT STYLE="font-weight: normal">
Section and subsection headings are inserted for convenience of reference only and do not form a part of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Counterparts.<FONT STYLE="font-weight: normal">
The parties may execute this Agreement in two or more counterparts, each of which shall be deemed an original.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amendment;
Waiver.<FONT STYLE="font-weight: normal"> This Agreement may be amended, modified, superseded or canceled, and any of the terms
may be waived, only by a written instrument executed by each party or, in the case of waiver, by the party waiving compliance.
The delay or failure of either party at any time or times to require performance of any provisions hereof shall in no manner affect
the rights at a later time to enforce the same. No waiver by either party of any condition or of the breach of any term contained
in this Agreement, whether by conduct, or otherwise, in any one or more instances, shall be deemed to be, or considered as, a further
or continuing waiver of any such condition or of the breach of such term or any other term of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Agency or Partnership.<FONT STYLE="font-weight: normal"> Nothing contained in this Agreement shall give either party the right
to bind the other, or be deemed to constitute either party as agent for or partner of the other or any third party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assignment
and Successors.<FONT STYLE="font-weight: normal"> This Agreement may not be assigned by either party without the consent of the
other, which consent shall not be unreasonably withheld, except that each party may, without such consent, assign this Agreement
and the rights, obligations and interests of such party to any of its Affiliates, to any purchaser of all or substantially all
of its assets or research to which the subject matter of this Agreement relates, or to any successor corporation resulting from
any merger or consolidation of such party with or into such corporation; provided, in each case, that the assignee agrees in writing
to be bound by the terms of this Agreement. Any assignment purported or attempted to be made in violation of the terms of this
Section 12.10 shall be null and void and of no legal effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Force
Majeure.<FONT STYLE="font-weight: normal"> Neither party will be responsible for delays resulting from causes beyond the reasonable
control of such party, including, without limitation, fire, explosion, flood, war, strike, or riot, provided that the nonperforming
party uses commercially reasonable efforts to avoid or remove such causes of nonperformance and continues performance under this
Agreement with reasonable dispatch whenever such causes are removed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interpretation.
<FONT STYLE="font-weight: normal">Each party hereto acknowledges and agrees that: (a) it and/or its counsel reviewed and negotiated
the terms and provisions of this Agreement and has contributed to its revision; (b) the rule of construction to the effect that
any ambiguities are resolved against the drafting party shall not be employed in the interpretation of this Agreement; and (c)
the terms and provisions of this Agreement shall be construed fairly as to both parties hereto and not in favor of or against either
party, regardless of which party was generally responsible for the preparation of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Severability.<FONT STYLE="font-weight: normal">
If any provision of this Agreement is or becomes invalid or is ruled invalid by any court of competent jurisdiction or is deemed
unenforceable, it is the intention of the parties that the remainder of this Agreement shall not be affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>IN WITNESS WHEREOF,</B> the parties
have caused this Agreement to be executed by their duly authorized representatives as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-family: Courier New, Courier, Monospace"><font style="font: 10pt Times New Roman, Times, Serif"><b>Bar Ilan Research and Development </b></font></td>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Courier New, Courier, Monospace"><font style="font: 10pt Times New Roman, Times, Serif"><b>T.A.B. Anti Bacterial Textiles Ltd.</b></font></td></tr>
<tr style="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-family: Courier New, Courier, Monospace"><font style="font: 10pt Times New Roman, Times, Serif"><b>Company Ltd.</b></font></td>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</td>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Courier New, Courier, Monospace">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="font-family: Courier New, Courier, Monospace; text-align: justify; width: 5%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace; text-align: justify; width: 42%; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/ Orli Tori</FONT></TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace; text-align: justify; width: 5%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By: </FONT></TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace; text-align: justify; width: 42%; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/ Joshua Herchcovici </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;Meir
Elishkov</FONT></TD></tr>
<tr style="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-family: Courier New, Courier, Monospace; text-align: justify">&nbsp;</td>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Courier New, Courier, Monospace; text-align: justify">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="font-family: Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace; text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Orli Tori</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name: </FONT></TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace; text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Joshua Herchcovici&nbsp;&nbsp;Meir Elishkov </FONT></TD></tr>
<tr style="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-family: Courier New, Courier, Monospace; text-align: justify">&nbsp;</td>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Courier New, Courier, Monospace; text-align: justify">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="font-family: Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title: </FONT></TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace; text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">CEO</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="font-family: Courier New, Courier, Monospace; text-align: justify; border-bottom: Black 1pt solid">&nbsp;</TD></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>EXHIBIT A</B>- DEVELOPMENT PLAN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1. Development of Roll To Roll machine of industrial scale</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;&nbsp;This milestone will be completed within
(18) months of Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2. Pilot production and troubleshooting</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;&nbsp;This milestone will be completed within
(26) months of Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">3. First serial production &amp; distributing to a selected
number of medical</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;&nbsp;institutions for performance and assessment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;&nbsp;This milestone will be completed within
(32) months of Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4. Regulatory approval of the product</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;&nbsp;This milestone will be completed within
(36) months of Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5. Serial production on industrial scale</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;&nbsp;This milestone will be completed within
(40) months of Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>EXHIBIT B</B>- Patent Applications</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title: Sonochemical coating of textiles
with Metal Oxide Nanoparticles for Antimicrobial Fabrics</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PCT no.: PCT/IL2009/000645</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">National Phase:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IL &ndash; appl. no. 209908, filed 29-06-2009</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">US &ndash; appl. no. 12/997,276, filed
on 10-Dec-2010</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">EU &ndash; appl. no. 09773041.0, 06-01-2011</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventors: Aharon Gedanken, Yeshayahu Nitzan,
Perelshtein Ilana, Perkas Nina, Applerot Guy</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title: DOPED METAL OXIDE NANOPARTICLES
OF AND USES THEREOF</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PCT/IL2014/050406, filed on 05-May-2014</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventors: Gedanken Aharon , Banin Ehud,
Perelshtein Ilana , Lubart Rachel , Lipovsky Anat , Malka Eyal , Yeshayahu Nitzan , Perkas Nina , Shalom Yakov , Lellouche Jonathan
, Patrick Tal , Eshed Michal , Naparstek Livnat</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="margin: 0pt 0; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
